INTRODUCTION
While the pandemic continues to influence businesses (especially
their bottom lines and other internal budgets), it hasn't
necessarily brought intellectual property ideation, protection,
commercialization and enforcement to a halt. In fact, businesses
have found, and continue to find, new ways in which they create and
protect their various intellectual properties.
Companies engaged in the pharmaceutical and FMCG industries,
especially, continue to commit enormous resources, including time
and money, into the creation, promotion and commercialization of
their various intellectual property rights. Such activities, on
some occasions, tend to push the boundaries of intellectual
property law and, as a result, end up in litigation.
